[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 184.73.122.162. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
May 1, 2002

Treatment of Congestive Heart Failure

Author Affiliations
 

Stephen J.LurieMD, PhD, Senior EditorIndividualAuthor

JAMA. 2002;287(17):2209-2210. doi:10.1001/jama.287.17.2209

To the Editor: In their Scientific Review article about the management of advanced heart failure, Dr Nohria and colleagues1 suggested that angiotensin II receptor blockers (ARBs) are a reasonable alternative for patients who cannot tolerate angiotensin converting enzyme (ACE) inhibitors because of severe cough or angioedema. Although we agree that ARBs, or a combination of hydralazine and a nitrate, constitute a reasonable alternative in patients experiencing persistent cough associated with receiving ACE inhibitors, we believe that ARBs in patients with a history of an ACE inhibitor–associated angioedema should only be used with extreme caution, if at all.

First Page Preview View Large
First page PDF preview
First page PDF preview
×